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Uncoupling proteins (UCPs) constitute a highly conserved subset of mitochondrial solute 
carriers. Discovered in small rodents in the early 1970’s, UCPs and their homologs have since 
been found in nematodes, plants, birds, and, most recently, in significant depots within humans 
(Krauss et al. 2005, Van marken Lichtenbelt 2009). Following activation by long chain fatty 
acids (LCFA, e.g. oleic acid) and reactive oxygen species (ROS, e.g. 4-hydroxynonenal 
(4HNE)), UCPs form a proton channel within the inner mitochondrial membrane and permit the 
influx of hydrogen ions from the inter membrane space into the mitochondrial matrix. UCPs 
effectively uncouple oxidative phosphorylation (OX-PHOS) from ATP generation, resulting in 
increasing oxygen consumption and dissipating the chemical energy in the form of heat. Found 
primarily in brown adipose tissue (BAT) of small hibernating mammals, the canonical role of 
uncoupling protein 1 (UCP1) in mammalian adaptive thermogenesis has been thoroughly 
studied.  However, UCP1 is not the only member of the uncoupling family found within BAT. 
Also playing a key role in this tissue is uncoupling protein 3 (UCP3), which is a close homolog 
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to UCP1. However, in spite of the fact that UCP3 shares more than 50% amino acid homology 
and tissue localization with UCP1, the true function UCP3 is very poorly elucidated. Part of the 
difficulty in determining this function lies in the expression levels of the UCP3 protein, which 
are hundreds of folds less than UCP1 in this tissue. In addition, their homologous structure 
makes teasing apart UCP3-specific phenomena from UCP1-mediated mechanisms very difficult 
using conventional techniques in cell and molecular biology.  
While UCP1 is almost exclusively found in BAT, UCP3 is expressed primarily in skeletal 
muscle (SKM), which lacks UCP1 completely (Krauss et al. 2005). Because UCP3 is so 
enriched in SKM, many studies have focused on its role in that tissue and have then tried to 
transpose these functions into BAT. As a result, UCP3 has been implicated in facilitating 
numerous biological processes, including non-adaptive facultative thermogenesis, affecting SKM 
oxidative capacity by modulating LCFA export, and ameliorating elevated levels of ROS-
mediated stress within the tissue via glutathionine (GSH) interacting moieties. Ultimately, 
however, little consensus exists on the function of UCP3 within SKM, and subsequently, even 
less is known about its purpose in BAT.  
Previous data has shown that murine UCP1 has the capacity to bind to itself and form 
homo-tetramers when expressed in vitro in recombinant E. coli (Hoang T. et al. 2013). Here we 
show that UCP1 interacts with UCP3 in BAT in vivo, supporting Hoang’s research above by 
showing that UCP1 has the capacity to not only homodimerize but potentially oligomerize with 
other UCP homologs. While many groups using UCP3-null mice have reported no gross changes 
in physiologic responses, data previously published in the lab showed that mice lacking UCP3 
were protected from potentially fatal hyperthermic effects when administered sympathomimetic 
agents such as 3,4-Methylenedioxymethamphetamine (MDMA), methamphetamine (METH), 
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lipopolysaccharide (LPS), or norepinephrine (NE) (Mills et al. 2003, Kenaston et al. 2010). This 
implies that UCP3 plays an intimate role in sympathetic nervous system (SNS) mediated 
thermogenesis. Based upon the foregoing, the primary goal of the research discussed in this 
thesis was to elucidate the functions of UCP3 within BAT. 
In this study, we recapitulated results seen by other students in this lab: that global UCP3-
null mice do indeed exhibit a blunted thermogenic response when treated with sympathomimetic 
agonists. In addition, despite the near-ubiquitous expression of UCP2 throughout the mammalian 
organism, this UCP is not involved in SNS-mediated thermogenesis (Arsenijevic et al. 2000). 
Our data shows that UCP3 is vital to the catecholamine-mediated thermogenic responses 
following sympathomimetic drug administration. When challenged by METH, UCP3-null mice 
were able to respond, albeit with a blunted increase in body temperature. Furthermore, when 
challenged by NE, a key neurotransmitter involved in mediating the responses initiated by the 
SNS following METH exposure, UCP3-null mice were able to mount half the hyperthermic 
response seen in WT littermates. However, UCP1/UCP3 double-null animals exhibited an almost 
four-fold hypothermic effect compared to WT littermates when challenged with NE. In addition, 
UCP1/UCP3 double-null mice were unable to restore body temperatures back to baseline values, 
an effect seen in all the other genotypes. This implies that UCP3 plays an important role in 
restoring body temperatures to physiological norms. Therefore, while the mechanism underlying 
the decreased responsiveness to NE remains unclear, it is clear that whether localized to SKM or 
BAT, UCP3 is a major player in the mammalian response to SNS-mediated thermogenesis and 
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Chapter 1 – Introduction 
 
The eukaryotic mitochondria is called the “powerhouse” of the cell. However, this 
moniker is a gross oversimplification of the diverse functions of the most important, if not the 
most functionally diverse, organelle. Mitochondria are responsible for a tremendous host of 
intercellular processes: from the synthesis of all the Citric acid cycle (TCA) intermediates, to 
beta-oxidation (β-ox), calcium signaling, ROS damage mediation, apoptosis, and perhaps the 
most famous – OX-PHOS coupled with adenosine triphosphate (ATP) generation. Furthermore,  
mammalian mitochondria are home to a family of solute carriers responsible for mediating the 
majority of non-shivering thermogenesis seen in mammals –UCPs. Twenty-first century science 
transformed a plethora of previously terminal conditions such as Acquired Immune Deficiency 
Syndrome (AIDS) and many cancers into manageable illnesses – kept in check by one pill a day. 
However, despite great advances in biology, mitochondrial related illnesses such as Huntington’s 
disease, Alzheimer’s, and rapid dementia still plague millions around the world.  
Current research suggests that states of over nutrition, where caloric consumption 
exceeds expenditure, drive mitochondrial dysregulation of the electron transport chain (ETC). 
Caloric excess continuously feeds substrate into the TCA cycle without providing an outlet for 
the dissipation of the excess ATP. This results in increased flux across the ETC creating a bottle-
neck effect at ATP synthase but stalling the electron handling machinery, leading to electron 
slippage off of the ETC and into the surrounding mitochondrial matrix. Here freed electrons can 
react with molecular oxygen generating the free radical superoxide. If this ROS is not quenched 
by ROS scavenging molecules such as GSH it will continue to harvest electrons from other 
mitochondrial substrates leading to the generation of even more deleterious ROS species, such as 
the peroxidated lipid 4HNE. 
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These and other ROS cause damage to the sensitive neurons making up the basal ganglia 
and other cerebral regions leading to the onset of debilitating neurological conditions. However, 
UCPs act as a safety valve throughout OX-PHOS, and have the capacity to alleviate the stress 
excess electrons cause to the ETC. Found within the mitochondrial matrix plasma membrane, 
these protonophores extrude protons from the intermembrane space into the matrix, decreasing 
the electrochemical gradient, and act as a safety valve on the ETC. By preventing this undue 
burden UCPs indirectly decrease ROS, prevent the cell from having an excess of ATP, burn 
excess energy, and allow the TCA cycle as well as OX-PHOS to proceed unhindered.  
Recently, exciting research has shown the existence of functioning depots of BAT in 
active, lean, adult males, sparking much resurgence in the interest in this group of protonophores 
(Van marken Lichtenbelt et al, 2009). With obesity affecting a staggering 30% of the United 
States adult population, the ability to dissipate excess caloric energy by activating BAT depots 
has become a very attractive therapeutic option, especially as pharmacologic intervention has 
proven grossly ineffective in combatting this disorder. By targeting UCPs, researchers have the 
ability to ameliorate these devastating illnesses while increasing the quality of life for millions 






Figure 1. Oxidative phosphorylation and ATP generation  After food is consumed, it 
may be stored for later use or directly transported into the mitochondria for metabolism. Once 
inside the mitochondria, metabolites enter the Citric Acid cycle and are oxidized to drive the 
extrusion of protons to the intermembrane space. Along with NADH and FADH2 as cofactors, an 
electron is shuttled from these complexes to coenzyme Q and then to complex III. Electrons are 
passed via heme groups within shuttling protein, cytochrome C, to complex IV where they are 
combined with 2 protons and molecular oxygen to catalyze the formation of water. Throughout 
this entire process, complex I, III, and IV, release protons into the intermembrane space, and 
UCPs shuttle protons back into the mitochondrial matrix. Protons from the intermembrane space 
generate an electrochemical gradient and power F1/F0 ATP synthase allowing for the formation 







Metabolism is the biological application of the first law of thermodynamics. It is the 
summation of every energetically consuming and generating reaction in an organism. Yet, 
despite this simplistic statement, an organism rarely functions at levels where most of its 
nutrients are immediately consumed. Despite great advances in research methodology, 
quantifying metabolism is still very difficult. Most studies typically measure basal metabolic rate 
(BMR), the metabolism of an organism at rest at thermoneutral temperatures (Argyropoulos 
2002). With these variables held constant, BMR is predominantly a reflection of the mass and 
metabolic capacity of internal organs, and is usually directly proportional to the complexity and 
size of the organism. (Mckechnie 2008) However, mammalian metabolism is not a static value 
and is actively under the influence of a confluence of factors such as nutritional status, age, sex, 
external temperature, and thyroid hormone activity (Silva 2001).  
The most comprehensive methods to assess whole-body metabolism involve utilizing 
plethysmography chambers. These chambers are specially constructed to establish an animal’s 
metabolic profile by collecting and analyzing urine, feces, as well as precisely monitoring 
changes in CO2/O2 gas volume and pressure to give a precise measurement for lung capacity 
(Criée et al. 2011). In addition, complementary techniques, such as dual energy x-ray 
absorptiometry, are often employed simultaneously to further assess the bone mineral density, fat 
and lean body mass, as well as water content of the animal.  However, these methods cost 
thousands of dollars to implement, making them prohibitively expensive for small studies. More 
conventional methodology utilizes aerobic respiration to measure metabolism. In these systems, 
an organism is placed into a sealed chamber enriched with CO2. Then, expired CO2 and inspired 
O2 is collected, analyzed, and translated into a rate of gas exchange. Unlike plethysmography 
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chambers, conventional respirometry utilizes a spectrophotometer-like construct where the 
change in the infrared spectrum following CO2 absorption can be plotted against the change in 
CO2 concentration using a photomultiplier tube and Lambert's law (Tøien, 2013).  
Additional methods of metabolic assessment utilize external thermogenic challenges, as a 
proxy metabolic measurement. Using an implanted temperature probe, changes in intraperitoneal 
body temperature are monitored following subcutaneous administration of thermogenic agonist 
such as NE, a SNS agonist which is known to cause a rise in core body (Melin et al. 1988). 
These changes are subtracted from a baseline body temperature and this magnitude is used to 
indicate the metabolic capacity to respond to the thermogenic challenge.  This eliminates the 
need for costly chambers and gas sensors. In addition, these types of studies provide researchers 
with a more mechanistic view of SNS-mediated metabolism rather than a broad calculation of an 
organisms’ basal metabolic rate which fluctuates greatly. 
 
 
1.2 Thermoregulation  
Thermoregulation and thermogenesis are two faces on the same metabolic coin. These 
processes are vital to developing life and differ greatly depending on the organism. Reptiles, 
frogs, crickets, and other ectotherms, organisms whose body temperature and metabolic rate 
depend greatly on their external temperature, use behavioral methods of thermogenesis, such 
as basking in the sun on a hot rock, to maintain their body temperatures. Ectotherms rely 
heavily on physiological methods of heat transfer to stay warm in fluctuating temperatures. 
For example, fish have evolved sophisticated countercurrent system of thermoregulation in 
which arteries and veins run very closely and counterparallel to one another. Heat is able to 
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diffuse down its temperature gradient to nearby blood vessels, facilitating the flow of heat 
around the body (Malte et al 2007). If the external environment is too warm, frogs will 
increase mucous secretion to decrease body temperature via evaporation. Conversely, if 
temperatures are too cold, many ectotherms will enter a state of torpor characterized by a 
tremendous drop in body temperature and metabolism. Ectotherms are essentially “frozen” in 
this state unable to move, reproduce, feed, or digest food for periods that can last as long as 
eight months (Hochaka et al. 1985). During this period the majority of fuel substrates comes 
from lipid stores but other energetic substrates, such as molecular oxygen, can be limiting if 
an organism spends most of its life submerged in water, like turtles. Yet, torpor ensures that 
oxygen and fuel conservation occurs while keeping anaerobic end products, such as lactate, 
at low levels, and prevents systemic acidosis due to CO2 accumulation. Ectotherms will 
actively seek areas of optimal temperatures to maintain homeostasis. As a consequence, their 
lifespan, body size, metabolisms, and energetic capacity are highly limited by their 
environment.  
In contrast, mammals, or endotherms, have the ability to live in almost any environment 
due to their internal mechanisms of thermoregulation. Unlike ectotherms, endotherms have 
an internal set temperature that does not fluctuate with environmental changes. Briefly, 
receptors in the skin feel changes in the ambient environment and send afferent signals to the 
anterior hypothalamus where signals are integrated with information received from the 
body’s baroreceptors and osmoreceptors. Body temperature can be manipulated further by 
the presence of prostaglandins, inflammatory cytokines, as well as SNS tone (Netea et al. 
2000).  If the environment is too cold, the brain acts in concert with other organs and tissues 
to increase body heat transmission by activating BAT, inducing vasodilation, and shivering. 
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In addition, animals may increase body heat transmission by participating in a variety of non-
exercise behaviors such as nesting, nursing, cuddling with littermates, or alternating their 
body postures (Hochaka et al 1985). 
 In addition to an internal set point, endotherms have evolved a number of unique 
advantages, such as fur and brown adipose tissue (BAT), to maintain a constant internal 
temperature, a process known as thermogenesis. Thermogenesis can be broken down into 
two primary categories: obligatory and facultative. Obligatory thermogenesis encompasses 
the metabolic energy necessary to run all of the biological processes within the organism: 
food absorption, digestion, and metabolism, movement, which is both voluntary and 
involuntary, as well as diet-induced thermogenesis (Himms-hagen 1995). Facultative 
thermogenesis can be rapidly initiated in situations which require additional energy to 
maintain homeostasis such as shivering, exercise, exposure to prolonged periods of cold, and 
is associated with the activation of SKM and BAT (Silva 2001). This increases blood flow 
around the body and initiates lipolysis, stimulating the activation of UCP3, the primary UCP 
found within SKM concurrently with the UCPs found in BAT. Thus, endotherms possess 
very high metabolic rates despite tremendous variation in body sizes and organismal 
complexities. These mechanisms facilitate their survival in varying environmental conditions 





1.3 Dysregulation of Thermogenesis: From Fevers to Hyperthermia  
One of the more understood thermogenic phenomena are fevers. A fever is defined by an 
elevation in core body temperature by 1-4°C (Saper et al. 1994). This elevation in temperature is 
common during bacterial infections and is thought to provide adaptive immunity to its host by 
increasing the efficacy of neutrophil and macrophage attacks, as well as impeding the replicative 
potential of the invading pathogen. Fevers are initiated when endogenous pyrogens cross the 
blood brain barrier and enter the hypothalamus. There they initiate a cascade of inflammatory 
signaling which leads to the production of prostaglandin E2 (PGE2) (Netea et al. 2000).  
Together with second messenger cyclic adenosine monophosphate (cAMP), PGE2 elevate body 
temperature and initiate the physiologic symptoms associated with fevers (Dinarello et al 1984).  
At one end of the spectrum low-grade fevers offer the host a range of physiological benefits. 
However, if the body temperature becomes too high heat strokes or malignant hyperthermia 
(MH) can result. Heat stroke occurs when body temperature is above 40°C. It is usually a direct 
result of environmental factors combined with the inability to dissipate heat efficiently due to 
infirmity, old age, or other factors (Glazer 2005). MH is a pharmacogenetic disorder that occurs 
in patients with an autosomal dominant mutation in their SKM ryanodine receptors. This results 
in a “leaky” ryanodine receptor that depletes the sarcoplastmic reticulum of its calcium stores, 
uncoupling calcium flux from muscular contractions in a mechanism similar to how UCPs 
uncouple OX-PHOS from ATP synthesis (Ferreiro et al. 2002, Ali et al 2003, Chelu et al. 2006). 
This futile cycle can be recapitulated in some patients by the administration of halogenated 
anesthetics like isoflurane. Depending on the severity, patients with MH can present with a 
variety of symptoms ranging from anxiety, muscular spasms, tachycardia, and even renal failure. 
If body temperatures are not rapidly decreased, over 50% of all MH patients will succumb to 
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death as a result of intravascular coagulation, rhabdomyolysis leading to renal failure, or cerebral 
edema (Jurkat-rott et al. 2000).  
An acute, non-genetic form of MH can occur in individuals who consume MDMA. MDMA, 
nicknamed “ecstasy” is a very popular club drug around the world. Upon oral administration, 
once MDMA has crossed the blood-brain barrier it triggers a large release of dopamine, 
serotonin, and NE onto the CNS as well as the periphery. The activation of lipolysis by 
circulating NE results in the liberation of FFA and subsequent activation of SKM UCP3. This, in 
conjunction with thyroid hormone levels is postulated to mediate the hyperthermic response seen 
with recreational MDMA use (Rusyniak et al. 2005). Furthermore, Sprague et al. prevented and 
attenuated MDMA-induced MH by treating patients with α1 and the β1,2,3 adrenergic receptor 
antagonist carvedilol, demonstrating that MDMA-induced MH is indirectly mediated by both the 
α1 and the β3 adrenoreceptors. (Sprague et al. 2005).  
 
 
1.4 Brown Adipose Tissue 
Brown adipose tissue (BAT) is a highly metabolic tissue found in the interscapular, perirenal, 
axillary, and paravertebral areas of many hibernating mammals including mice, rats, and 
hamsters (Casteilla et al. 2008). In small rodents BAT depots continue to develop and grow until 
the animal is sexually mature. However, BAT expression in humans differs greatly from rodents 
where it localizes primarily on the ventral side of the body between the shoulder blades and 
gradually atrophies as the infant develops into adulthood. Recent studies utilizing fluorescent 
tracers have shown that BAT is present in active, lean males with expression directly relating to 
levels of exercise and activity (Van marken lichtenbelt et al. 2009). This discovery has sparked 
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great re-interest in the metabolic capacity of this tissue. After infancy, BAT localization shifts to 
the dorsal side of the body where it is found mostly around the sternum and the interclavicle 
areas (Van marken lichtenbelt 2009). Here, in conjunction with white adipose tissue (WAT) and 
thyroid hormone, BAT is intimately involved in body temperature regulation of the abdomen and 
internal organs. 
Containing an abundance of UCP1, BAT is responsible for maintaining body temperature, 
especially during periods of intense cold. This differs starkly from WAT – which functions 
mainly as an energy storage organ and endocrine regulator releasing adipokines such as leptin, 
ghrelin, and adiponectin during various states of organismal nutrition. However, BAT adipocytes 
are distinctly different from WAT adipocytes. BAT adipocytes differ greatly in their 
morphology, gene signatures, mitochondrial content, enzymatic capacity, and lipid mass. Even 
before the distinct tissues arise during organogenesis, BAT progenitor stem cells arise from the 
same population of Myf5+ stem cells which will grow to become SKM, not WAT (Seale et al. 
2008, Martinez-lopez et al. 2013). Furthermore, the fully differentiated BAT adipocyte exhibits a 
multilocular appearance, with its lipid content stored in an abundance of small lipid-dense 
droplets which surround the nucleus. WAT adipocytes, in contrast, usually contain one large 
acentric lipid vacuole. Another important distinction between the two tissues is mitochondrial 
content. BAT is brown because of its enrichment in mitochondria, specifically cytochrome C. 
This enrichment allows BAT adipocytes to express and store exponentially more fatty acid 
metabolizing and ROS-quenching enzymes than its WAT counterpart (Forner 2009). In fact, it 
has been postulated that UCP1 makes up almost 8% of the BAT mitochondrial proteome 
(Rousset et al. 2007). Conversely, WAT is enriched in enzymes responsible for endocrine 
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communication as well as xenobiotic transformation and matched the gene signature of the liver 
more closely than that of BAT (Forner et al. 2009).  
Recently, subcutaneous depots of “beige” cells have been found in WAT (Harms et al. 
2013). These are WAT adipocytes stimulated to differentiate into BAT-like cells following 
treatments of cold or β3 adrenergic receptor agonists (Wang et al. 2013). While beige adipocytes 
share BAT adipocyte morphology as well as express low levels of UCP1, UCP3 has not been 
found in this group of cells. Furthermore, beige cells originate from WAT precursor Pdgfr-α+ 
Myf5- progenitor stem cells and are regulated by different transcription factors and 
pharmacologic agonists than BAT adipocytes. Furthermore, the function of beige cells is under 
intense scrutiny. While very little is known, some hypothesize that the importance of beige cells 
lies not in their absolute number, but in the ratio of beige to classical WAT adipocytes, which 




1.5 Mammalian Bioenergetics 
 
Unlike plants which use chloroplasts to harvest their own energy via photosynthesis, 
most living organisms must obtain energy by the consumption of external fuel sources. This 
results in the generation of ATP – the ubiquitous energy currency used by all kingdoms of life. 
Generated within the mitochondria, this energetic substrate allows the mammalian organism to 
perform a broad array of functions: growth and development, thermoregulation and metabolism, 
and reproduction. Bioenergetics describes the cyclical flow of chemical energy into and out of an 
organism (Mckechnie 2008) In mammals, this chemical energy is often lost through the 
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production of body heat, which, in addition to being energetic waste, serves to protect mammals 
from the cold and maintain homeostasis. Thus, many researchers use body heat production as an 
indirect measurement of metabolism and energetic efficiency.  
 Mitochondria are made up of two separated plasma membranes (PM) forming an inner 
matrix and an intermembrane space. Situated within the inner mitochondrial membrane is where 
OX-PHOS occurs (Figure 1.1). Briefly, NADH/FADH2 transfer their electrons to complex I and 
II of the electron transport chain (ETC). From there electrons are transported by Coenzyme Q to 
complex III where Cytochrome C shuttles electrons to complex IV. As this process occurs, 
complex I, III, and IV, release protons into the intermembrane space, generating an 
electrochemical proton gradient and membrane potential across the inner mitochondrial PM. 
Complex V, or ATP Synthase, then uses this proton gradient to drive the phosphorylation of 
adenosine di-phosphate into ATP.  
Disease pathophysiology occurs when the steady flow of electrons across this chain is 
disrupted. Electron slippage occurs in states of organismal stress: commonly in overnutrition or 
extreme exercise, especially between the complexes mediated by electron carrier coenzyme Q 
and cytochrome C. If freed electrons are not captured by electron scavenging proteins such as N-
acetyl cysteine, they will bind to any available matrix protein or mitochondrial substrate leading 
to the gross accumulation of superoxide and other ROS. This catalyzes a sequence of reactions 
where by less reactive ROS bind to milieu in the surrounding matrix generating even more 






1.6 Uncoupling Proteins 
Uncoupling proteins are transmembrane protonophores located within the inner 
mitochondrial membrane. Like their name suggests, UCPs de-couple the proton electrochemical 
gradient from ATP synthesis, decreasing the proton flux and membrane potential across the inner 
mitochondrial membrane. During OX-PHOS, mitochondrial complex I, III, and IV pump protons 
into the intermembrane space. These protons establish the electrochemical gradient and 
mitochondrial membrane potential that drives complex V, ATP synthase, to catalyze the 
formation of ATP from adenosine diphosphate (ADP) and inorganic phosphate back across the 
matrix membrane. At elevated ratios of ATP to ADP, mitochondrial machinery begins to slow 
down due to ATP synthase inhibition by excess ADP (Kishikawa et al. 2014). UCPs act as a 
proton channel extruding protons from the intermembrane space back into the matrix, decreasing 
the mitochondrial membrane potential and electrochemical gradient. Thus, by decreasing the 
proton availability to ATP synthase, UCPs ensure that mitochondria never possess supramaximal 
levels of ATP. However, if substrates are continuously fed into the mitochondria while electron 
flux is slowed this can lead to slippage off of the electron handling machinery, leading to undue 
ROS burden and mitochondrial damage. 
 Like many biological processes, UCPs are regulated by both negative and positive feedback 
loops. When ATP levels become too low, ADP is in abundance. Purine nucleotides like ADP and 
GDP inhibit UCPs, preventing proton leakage, and allowing for an increase of protons in the 
intermembrane space, pushing complex V and promoting ATP formation [cite here]. 
Conversely, research has shown that UCPs are activated by long chain fatty acid  (LCFA) anions 
at both the protein and transcriptional level (Mochizuki et al. 2006, Fedorenko et al. 2012). A 
diverse group of polyunsaturated FA species bind to and stimulate the activity of peroxisome 
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proliferator-activated receptor alpha, beta, and gamma (PPARs), transcription factors which have 
response elements upstream of both UCP1 and UCP3 promoters. At the protein level, the LCFA 
hydrocarbon tail binds to the cytoplasmic face of UCP1 due to their hydrophobic interactions 
(Fedorenko et al. 2012). Upon protonation, the LCFA anion causes UCP1 to undergo a 
conformational change, releasing the proton into the mitochondrial matrix. Many FA substrates 
are capable of binding to UCP1, however research has shown that a higher proton gradient is 
required to effectively protonate lower pKa FA species. Furthermore, it has been demonstrated 
that ROS, specifically, 4-HNE and superoxide are potential activators of UCPs, although the 
mechanism behind such activation is unknown (Echtay et al. 2002). This positive regulation of 
UCPs by ROS is interesting as it suggests that some basal concentration of ROS must exist to 
trigger the ameliorative actions of UCPs.  
At the transcriptional level UCPs are tightly regulated by a large host of transcription factors 
including PPARs, peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
(PGC1α) CCAAT enhancer binding proteins (CEBP1α), thyroid hormone, cyclic adenosine 
monophosphate (cAMP), and retinoic acid, among others, which must be present for strong gene 
induction (Acín 1999, Solanes 2003 & 2005). Cyclic-AMP is an especially important second 
messenger because it catalyzes the majority of SNS-mediated uncoupling as a response to cold, 
fever, or thermogenic drugs. Lastly, some hormones like insulin-like growth factor 1 (IGF-1), 
induce UCP gene expression. Conversely, glucocorticoids have been shown to reduce UCP gene 
expression, perhaps due to their transcriptional activity on NE. However, elucidated mechanisms 





1.7 Uncoupling Protein 3 
Another protonophore found within the mitochondria of BAT is uncoupling protein 3 
(UCP3). Despite being 50% structurally homologous to UCP1, the function of UCP3 in BAT is 
very poorly understood. This difficulty lies primarily with fact that UCP3 is expressed 500 fold 
less than UCP1 in BAT, making it very difficult to tease apart UCP3-specific effects. (Harper 
2001, 2002). Thus, much of what is known about UCP3 is extrapolated from SKM, where UCP3 
predominates, but which has a complete dearth of UCP1. Furthermore, an overall idea of the 
function of UCP3 is convoluted, with different groups reporting contrasting results. 
Studies assessing the function of UCP3 in UCP3-null mice found that there were almost no 
global physiological changes as a result of UCP3 deletion (Gong 2000, Vidal-puig 2000, Harper 
2001, 2002). Body weight, serum analysis including insulin, TG and FFA oxidation were all 
unchanged from controls. Furthermore, thermogenic responses to exposure to 4°C for 1 hour, 4 
hours, and 24 hours was no different from wild-type littermates. Resting oxygen consumption 
following injection with β3-adrenergic agonist CL314263 resulted in increases of the same 
magnitude in both genotypes, suggesting a lack of UCP3 involvement in SNS-mediated 
thermogenesis (Gong 2000). Yet, groups have found that mice subcutaneously administered SNS 
agonist 3,4-methylenedioxymethamphetamine (MDMA) were protected from the drug’s acute 
hyperthermic effects, indicating that UCP3 does indeed play a role in thermogenesis (Mills et al. 
2003, Sprague et al. 2004, 2007). Furthermore, the majority of the studies performed in UCP3-
null mice were conducted in mitochondria from SKM, where UCP3 predominates (Gong 2000, 
Vidal-puig 2000). These authors are incorrect in making gross extrapolations about the function 
of UCP3 within BAT from their limited investigation of its function in SKM, a tissue with 
drastically differing structures, functions, and tissue environment from BAT. 
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The studies above reported increases in levels of ROS in UCP3-null SKM mitochondria, 
findings that have been confirmed by other groups (Vidal-puig 2000). These same levels of ROS 
production could be re-created in WT mice with the treatment of mild uncoupler FCCP, 
postulating that UCP3 decreases ROS via mild uncoupling mechanisms (Toime et al. 2010). 
Within the mammalian cell, the generation of ROS is very tightly coupled to perturbations within 
the membrane potential. Thus, it is possible to see pronounced decreases in ROS production with 
even mild uncoupling by UCP3. However, this phenomenon was argued to be due to increased 
activity of adenosine nucleotide translocator (ANT) protein and not UCP3 (Bevilacqua 2010). 
Other studies assessing levels of 4HNE or carbonylated protein production in UCP3-null SKM 
mitochondrial found no difference among genotypes (Nabben 2011). While other groups found 
that significant increases in ROS could be mimicked by placing UCP3-null mice on a 2 month 
high-fat diet, indicative of substrate-specific UCP3 effects. (Nabben 2011).   
Yet, other groups believe that the effects of UCP3 on ROS are indirect and not due to 
classical uncoupling (Maclellan et al. 2005). Within the mammalian cell ROS quenching occurs 
via scavenging molecules such as GSH, and N-acetyl cysteine. Some groups have found reactive 
cysteine residues on UCP3 that have the capacity to conjugate with GSH (Mailloux et al. 2011). 
They hypothesize that elevated levels of ROS sequester available GSH, triggering the 
uncoupling capacity of UCP3 in situations of increased ROS burden. Currently, no consensus 
exists but studies of UCP3 polymorphisms in humans have been linked to metabolic disorders 
associated with ROS signaling, GSH synthesis, FA oxidation and impaired TG oxidation 





1.8 Summary and Concluding Remarks 
It is clear that the energetic demands of endotherms are costly yet come with many 
advantages. The capacity to maintain thermal homeostasis allows mammals to live in a variety of 
environments, while allowing them to grow to larger sizes and have more complex metabolic 
and circulatory systems. Specialized tissues like BAT and SKM allow vertebrates to participate 
in both obligatory thermogenesis as well as activate facultative thermogenesis via shivering 
whenever additional body warmth is needed. On a molecular level, both of these events are 
powered by ATP generated within the mitochondria. Consumption of a variety of substrates 
powers the TCA cycle, generating sugar intermediates, which enter the ETC. These 
intermediates are donated to the various complexes of the ETC along with reducing cofactors 
that facilitate the flux of electrons as they move through each complex. As electrons are shuttled 
down the ETC, complexes I, III, and IV, pump protons into the intermembrane space, generating 
an electrochemical gradient across the inner mitochondrial membrane. This proton motive force 
serves to push protons into ATP synthase and facilitate the phosphorylation of ADP and 
inorganic phosphate to ATP, the energetic currency of the body.  
UCPs de-couple the ETC from the generation of the membrane potential, allowing protons to 
flow back into the mitochondrial matrix. By serving as a “safety-valve” for OX-PHOS, UCPs 
prevent the accumulation of supramaximal levels of ATP, as well as ensure the steady flow of 
electrons across the ETC, preventing electron slippage off of handling machinery and the 
generation of deleterious ROS. Canonical UCP1 is found almost exclusively in BAT where its 
role and importance in adaptive thermogenesis has been well elucidated. However, the function 
of its homolog, UCP3, remains poorly understood, and very difficult to decipher. Expressed 
primarily in SKM, the role of UCP3 in BAT is highly controversial. Part of the difficulty lies in 
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separating UCP1-mediated effects from UCP3 – functions which could overlap, be 
complementary, or even synergistic to one another.   
The primary goal of this study was to elucidate the effects of UCP3 in BAT. Some groups 
have found that UCP3 plays an important role in the redox regulation of mitochondria, while 
others have found that UCP3 in not involved in any aspect of mammalian metabolism (Mailloux 
et al., Nabben 2011). It is clear that UCP3 is involved in thermogenesis – at least in 
amphetamine-mediated conditions, suggesting that UCP3 may be activated under special 
circumstances. (Mills et al. 2003). However the true function of UCP3 in BAT is unclear. Much 
of what is known has been extrapolated from studies assessing the function of UCP3 in SKM, in 
animals where UCP3 has been globally deleted, or overexpressed to supraphysiological levels. 
However, UCP3 is the only UCP in SKM, where the redox environment grossly differs from that 
of BAT mitochondria (Mailloux et al. 2012). Thus, it is entirely plausible that the function of 
UCP3 in BAT differs from that in SKM. While many groups have attempted to explain the 
mechanisms involved in UCP3-mediated thermogenesis, no universal consensus exists. This 
study seeks to give more insight into the mechanisms underlying UCP3-mediated thermogenesis 
as well as to provide mechanistic insight into its interactions with partner proteins in BAT. Data 





Chapter 2 – Methods and Materials 
 
2.1 Chemicals and Reagents  




C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME). C57BL6/J 
UCP3 -/- mice were a gift of Dr. Marc Reitman, formerly of the National Institutes of Health. 
C57Bl6/J UCP1 -/- mice were gifted by Dr. Leslie Kozak of the Pennington Biomedical 
Research Institute. UCP1/UCP3 Double-null mice were generated by breeding UCP1-/- mice to 
UCP3-/- mice and their genotypes verified via polymerase chain reaction (PCR) analysis. 
Animals were housed in a 12 hour light/dark cycle and fed Prolab RMH 2000 5P06 (5% fat) 
chow. Mice to be used for experimental procedures were switched to Prolab RMH 2000 9P06 
(9% fat) at 6 weeks of age and maintained on this diet for at least 2 weeks. All procedures were 
approved by the University of Texas Institutional Animal Care and Use Committee.  
 
2.3 PCR 
UCP1/UCP3 double-null animal genotypes were confirmed via PCR. Briefly, following 
weaning, mouse tails were clipped, and DNA isolated using the Wizard Genomic DNA 
Purification Kit (Promega, Fitchburg, WI) exactly as per the manufacturer’s instructions. DNA, 
positive, and negative controls were then added to individual PCR tubes followed by a master 
mix containing 10X Advantage® 2 SA PCR Buffer (Clonetech, Mountain View, CA), 10mM 
dNTPs, and Taq polymerase (Clonetech, Mountain View, CA). For mUCP3, three 20uM unique 
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primer sequences were added to the master mix: 5'- CTC CAT AGG CAG CAA AGG AAC- '3, 
5' - CAA GCA AAA CCA AAT TAA GGG -'3, 5' - CCA CTA TAT GGT TTA CAC AGC -'3. 
For mUCP1 three separate and unique 20uM primer sets were added to its master mix: 5’ - CCT 
AAT GGT ACT GGA AGC CTG- ‘3, 5’ - CCT ACC CGC TTG CAT TGC TCA- ‘3, 5’ - GGT 
AGT ATG CAA GAG AGG TGT- ‘3. Cycling conditions for mUCP3 were as follows: initial 
denaturing at 94° C for 5 minutes, followed by 35 cycles of 94° C for 1 minute, 60° C for 1 
minute, and then annealing at 72° C for 1 minute. Cycling conditions for mUCP1 were identical 
to mUCP3 with the 35 cycle denaturing temperature at 58° C for 1 minute. Once the PCR was 
complete, 6X loading dye (30% (v/v) glycerol, 0.25% (w/v) bromophenol blue, 0.25% (w/v) 
xylene cyanol FF) was added to each sample was separated via DNA-gel electrophoresis on a 
1% agarose gel with ethidium bromide (Fischer Scientific, Waltham, MA) and results confirmed 
using a Biorad UV transiluminator coupled to a camera. 
 
2.4 Tissue Isolation from Mice 
Six to eight-week-old male C57BL/6 mice were euthanized via CO2 asphyxiation, tissues 
excised and immediately placed into ice-cold CP-1 buffer (100mM KCl, 50mM Tris HCl, 2mM 
Ethylene glycol tetraacetic acid (EGTA), pH 7.4, supplemented with 200mM 
Phenylmethylsulfonyl fluoride (PMSF), 1uL/10mL Leupeptin, 1uL/10mL Pepstatin, 7uL/10mL 
10,000KIU/mL Aprotonin, 0.42mg/mL NaF, and 200mM Sodium Orthovanadate) Remaining 






2.5 Isolation of Mitochondria  
 Using a clear glass pestle tissue grinder, samples were completely homogenized and 
diluted 1:1 with equal volume of CP-1 buffer with 0.2% FA free bovine serum albumin (BSA). 
Tissues were centrifuged at 600 x g for 5 minutes at 4°C, and the supernatant transferred to a 
fresh conical. This spin was repeated once more at 700 x g and the supernatant filtered through a 
70um cell strainer (Corning, Tewksbury, MA). Tissues were then centrifuged at 7000 x g for 10 
minutes at 4°C to isolate mitochondria, the supernatant discarded, and the pellet resuspended in 
CP-1 buffer without BSA. Mitochondria were washed 3 additional times in ice-cold CP-1 buffer, 
centrifuged at 7000 x g for 10 minutes at 4°C. Samples were resuspended in 30-60uL of 
Hirasaka IP Buffer (50mM Tris HCl, 150mM NaCl, 5mM EDTA, 1% Triton X, pH 8, 
supplemented with 200mM PMSF, 1uL/10mL Leupeptin, 1uL/10mL Pepstatin, 7uL/10mL 
10,000KIU/mL Aprotonin, 0.42mg/mL NaF, and 200mM Sodium Orthovanadate) or RIPA 
buffer (50mM Tris-HCl, 1% nonyl phenoxypolyethoxylethanol (NP-40), 0.5% Sodium 
Deoxycholate, 0.1% SDS, 150mM NaCl, 2mM EDTA, pH 8.0, supplemented 200mM PMSF, 
1uL/10mL Leupeptin, 1uL/10mL Pepstatin, 7uL/10mL 10,000KIU/mL Aprotonin, 0.42mg/mL 
NaF, and 200mM Sodium Orthovanadate). 
 
2.6 Protein Quantification  
Protein quantity was determined by via bicinchoninic acid assay (Thermo Scientific 
Pierce, Rockford, IL) exactly as per the manufacturers’ instructions using BSA as a standard. 






 To prepare samples for SDS-PAGE following protein quantification, a 5X concentrate of 
250mM Tris HCl, 8% SDS, 40% glycerol, 8% β-mercaptoethanol, 0.02% bromophenol blue was 
added to lysates, boiled 5 minutes at 100°C, cooled on ice for 5 minutes, centrifuged at 10,000 x 
g for 5 minutes, and then the protein supernatant loaded into a 12.5 polyacrylamide gel. Proteins 
were separated on 12.5% polyacrylamide gels at 100V through the stack, and then 200V through 
the resolving portion of the gel at RT until the dye front ran was no longer visible, about 1hr. 
Proteins embedded within the gel were transferred to a nitrocellulose membrane for 1hr at 100V 
at RT and the probed with primary antibodies as per the manufacturer’s instructions: mouse 
polyclonal UCP1 (Abcam, Cambridge, MA), and mouse polyclonal mitofusin-1 (Abcam, 
Cambridge, MA) were resuspended at 1:1000 in 5% milk in 1X TBST from 1-4 hours at 4°C. 
The primary antibody for mUCP3 was custom generated for the laboratory by Washington 
Biotechnology (Columbia, MD) and used at 1:3000 in 5% milk in 1X TBST from 12-16 hours at 
4°C. Secondary antibodies were donkey anti-rabbit IgG, (GE Healthcare, UK). Following 
incubation for 1 hour at RT, membranes were developed using Super Signal West 
Pico/Femto/Dura chemiluminescent substrate (Pierce, Rockford, IL) 
 
2.8 Immunoprecipitation 
 Following protein quantification, 250ug of mitochondrial protein lysate was resuspended 
in 300uL of Hirasaka IP buffer to eliminate non-specific interactions within samples, 1:10 (v/v) 
of washed Protein A/G Sepharose beads (GE Healthcare, UK) were added to samples and 
allowed to nutate at 4°C for 1 hour. Samples were centrifuged at 10,000 x g for 5 minutes at 4°C 
and the supernatant transferred to a clean Eppendorf tube. Following this, 2ug of primary 
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antibody (mUCP1) or IgG control was added to each sample and allowed to rotate end-over-end 
from 2-4 hours at 4°C. Fresh protein A/G Sepharose beads were thoroughly washed in Hirasaka 
IP Buffer added at 1:10 (v/v) to samples and were incubated with rotation for at least 4 hours at 
4°C. Samples were then centrifuged at 10,000 x g for 5 minutes at 4°C, washed five times with 
Hirasaka IP buffer, and prepared for immunoblotting via SDS-PAGE as described above.  
 
2.9 Intraperitoneal Temperature Probe Placement 
 The mouse ventral, right flank was shaved from knee to elbow prior to surgery and mice 
were placed into an isoflurane-filled chamber until animals no longer exhibited the righting 
reflex. Once sedated, mice were moved to isoflurane under the nose cone, injected with a pre-
operative subcutaneous dose of 1.25mg/kg of Rimadyl (Zoetis Inc., Florham Park, NJ), and the 
surgical area sterilized using a sterile povidone solution.  Utilizing asceptic technique, a small 
transverse cut was made on the previously shaved flank and the skin spread apart to expose the 
peritoneum. The same cut was repeated to open the peritoneal cavity and a wireless temperature 
probe (Starr Life Sciences, Holliston, MA) inserted into the cavity without adhesion to the 
peritoneal wall. The peritoneal incision was sealed using nonabsorbable vicryl sutures, the skin 
was closed using sterile skin staples, and mice allowed to recover until fully alert on a heated 
pad. Twenty-four hours post-op, mice were assessed for signs of infection or duress and given a 
follow-up subcutaneous dose of 1.25mg/kg of Rimadyl. Mice were allowed to recover for 5-7 






2.10 Administration of Thermogenic Agonists 
 Male mice ages 7-8 weeks were weighed, placed into clean cages containing 70g of 
bedding with ad libitum access to food and water, and placed into a 25°C environment for all 
temperature studies. Mice were given twenty minutes to acclimate to the 25°C environment prior 
to recording baseline body temperatures. Subcutaneous injections of either 20mg/kg 
methamphetamine, or 2mg/kg norepinephrine bitartrate were prepared in sterile saline and 
injected subcutaneously into the interscapular area, distant from the surgical sites. Body 
temperatures were recorded using the Vital View software (Starr Life Sciences, Holliston, MA) 
as per manufacturers directions. 
 
 
2.11 Statistical Analysis  
 Statistical evaluation of thermogenic data was performed via IBM SPSS with 





Chapter 3 – UCP1 interacts with UCP3 in BAT 
 
Brown adipose tissue is the canonical organ for thermogenesis in small rodents, with 
UCP1 typically thought of as the key player. However, more research points to UCP3 as a 
significant auxiliary contributor to UCP1. Studies have shown that UCP3 has the capacity to 
bind proteins at transmembrane regions as well as N or C-terminal  residues (Pierrat et al. 2000, 
Kenaston 2010, Hirasaka et al. 2011, Mailloux et al. 2011). In addition, it has recently been 
shown that UCP1 has the capacity to form tetramers with itself (Hoang et al. 2013). Thus, it is 
possible that UCP1 and UCP3 could form oligomers to synergistically augment or facilitate the 
uncoupling activities of this tissue. 
To test whether UCP1 can indeed interact with UCP3 in this tissue, we 
immunoprecipitated murine UCP1 from WT and UCP3-null BAT lysates and immunoblotted 
with an antibody against murine UCP3 (Figure 2). Following immunoblotting we found a BAT 
specific interaction between the WT UCP1 and UCP3 that is absent in the UCP3-null samples. 
However, this immunoprecipitation fails to yield results about the nature of the protein-protein 
interaction. In this context UCP3 could be directly binding to UCP1 to augment and facilitate the 
thermogenic response, functioning in an auxillary capacity by exporting LCFA into the 
mitochondrial matrix to provide an activating substrate for UCP1, functioning in a scaffolding 
capacity or an effector molecule, mediating ROS generation, or a variety of these functions 
simultaneously. Further experiments using purified recombinant proteins will uncover the role of 
UCP3 in this interaction: whether the binding is direct or indirect, and finally, which amino acid 
residues on both UCP1 and UCP3 mediate this interaction. In addition, the strength of the 
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interaction can be assessed in the presence of classical UCP activators: treatment with NE, or a 








Figure 2. UCP1 interacts with UCP3 in BAT. BAT from WT and UCP3-null mice was 
excised, processed, and its mitochondrial content purified via density centrifugation. Two 
hundred and fifty micrograms of mitochondrial lysates were immunoprecipitated with the murine 
UCP1 antibody or IgG controls and samples prepared for standard 12.5% SDS-PAGE and 
immunoblotting with αUCP3 antibody.  
IP: αUCP1 









Chapter 4 – UCP1/UCP3-double null mice exhibit blunted responses to thermogenic 
challenges 
 
Our current understanding of thermoregulation points to UCP1 as the primary mediator 
of this mechanism in BAT. However, the role of UCP3 within this tissue is completely unknown. 
Research from our lab and others has shown that UCP3 has an important and definitive role in 
mammalian thermogenesis. UCP3-null mice administered MDMA present with a blunted 
thermogenic response compared to their WT littermates (Mills et al. 2003, Sprague et al. 2004, 
2007). This response has been recapitulated in our lab with the administration of other 
thermogenic agonists as well, including methamphetamine and lipopolysaccharide (Kenaston 
2010). One hypothesis to explain this phenotype postulates that UCP1 and UCP3 interact 
together additively or synergistically and help mediate the thermogenic response seen upon 
administration of sympathomimetic agents. This protocol challenged mice with a non-lethal, 
subcutaneous dose of thermogenic agonists methamphetamine or norepinephrine and monitored 
changes in body temperature. When methamphetamine reaches the mammalian brain it results in 
a massive release of norepinephrine throughout the entire body via sympathetic nerve endings 
(Kish 2008). This also results in the stimulation of the cardiovascular system with concurrent 
increases in heart hate and blood pressure. Hyperthermia is another common side effect of many 
stimulating drugs of abuse and hyperthermic responses have been well documented in humans, 
as well as in many other mammals (Sprague et al. 2004, 2005, Levi et al. 2012) 
This study accomplished two goals: it confirmed results which had been previously 
generated - that UCP3-null mice fail to mount a hyperthermic response when challenged with 
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thermogenic agonist methamphetamine, and it provides a first glimpse at the mechanism 
responsible for this phenotype: a blunted physiological response to norepinephrine (NE).  
Twenty minutes after being challenged with a subcutaneous dose of 20mg/kg 
methamphetamine, all three genotypes reached statistically significant differences in body 
temperature. Temperature changes peaked at 40 minutes with WT mice having an average 
increase in body temperature of 1.75 ± 0.11°C (Figure 3). This response was significantly 
blunted in UCP3-null animals who exhibited half the thermogenic response of their WT 
littermates with raises in body temperature by only 0.75  ± 0.19°C.  Most striking, however, is 
the abolishment of any hyperthermic response in the UCP1/UCP3 double-null animals. These 
animals actually exhibited a hypothermic response and had a drop in body temperature by -0.87 
± 0.29°C. Furthermore, all three genotypes were able to return their body temperature back to 
baseline as the methamphetamine was metabolized from their body.  
Next, we decided to determine whether the changes in body temperature were 
definitively due to norepinephrine, or the independent actions of methamphetamine. Indeed, 
when subcutaneously challenged with 2mg/kg norepinephrine bitartrate, results were very 
similar to the challenge with methamphetamine only on a slightly earlier timescale. This is 
explained by the fact that methamphetamine must penetrate the brain before it can exert its 
actions on the rest of the body. Administration of NE alone does not require this penultimate step 
and can begin acting on the periphery in less time. In WT and UCP3-null mice changes in body 
temperature peaked twenty minutes after subcutaneous administration of 2mg/kg norepinephrine 
bitartrate with an average increase of 0.87 ± 0.15°C and 0.47 ± 0.15°C (Figure 4). Double-null 
animals exhibited a sharply contrasting hypothermic response, with body temperatures 
plummeting to -0.34 ± 0.09°C twenty minutes following the thermogenic challenge and reaching 
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their lowest temperature of -0.50 ± 0.19°C at 60 minutes. Furthermore, unlike all three genotypes 
in the methamphetamine challenge, UCP1/UCP3 double-null mice failed to bring their body 
temperatures back to baseline values following the NE challenge – suggesting that UCPs may be 












Figure 3. UCP1/UCP3-double null mice exhibit hypothermic responses when challenged 
with methamphetamine. WT (n=14), UCP3-null (n=10), and UCP1/UCP3-double null (n=6) 
mice were subcutaneously injected with 20mg/kg methamphetamine and their change in body 
temperature recorded using telemetry probes. WT mice exhibited the most robust hyperthermic 
response, followed by UCP3-null mice that had 50% the hyperthermic response of WT mice. 
UCP1/UCP3 double-null mice showed a greater than 100% hypothermic response compared to 
WT mice.  Data represent averages with error bars representing standard error of the mean 
(SEM) from at least 3 independent experiments. Statistics were done by an ANOVA followed by 
a Newmans’ post hoc test. * = p < 0.05 WT x UCP3-null, # = p < 0.05 WT x Double-null, & = p 





Figure 4. UCP1/UCP3-double null mice have a blunted thermogenic response to NE. WT 
(n=5), UCP3-null (n=7), and UCP1/UCP3-double null (n=4) mice were subcutaneously injected 
with 2mg/kg norepinephrine bitartrate and their change in body temperature recorded using 
telemetry probes. WT mice exhibited the most robust hyperthermic response, followed by UCP3-
null mice that had 50% the hyperthermic response of WT mice. UCP1/UCP3 double-null mice 
showed a 50% hypothermic response compared to WT mice. Data represent averages with error 
bars representing standard error of the mean (SEM) from at least 3 independent experiments. 
Statistics were done by an ANOVA followed by a Newmans’ post hoc test. * = p < 0.05 WT x 





Chapter 5 - Conclusions and Future Directions 
 
Currently, there is no mechanism to explain the hypothermic responses seen in 
UCP1/UCP3 double-null animals. Following subcutaneous administration of NE, this agonist 
circulates in the bloodstream before binding to its target receptors around the body.  This results 
in varying effects at differing tissues. In BAT, NE activation results in the initiation of lipolysis – 
the breakdown of triglycerides into glycerol and the release of FFA. These FFA are then 
imported into the mitochondria where they are oxidized and can serve as activating substrates for 
UCPs. Furthermore, activation of the SNS results in increased flux across the ETC and 
concurrent increases in ROS. Both FFA and various ROS are potent activators of UCPs. With 
abundant substrates, UCPs can then maximally uncouple respiration from ATP synthesis and 
generate the most heat possible. Elsewhere in the body, NE acts as a potent vasoconstrictor 
(Hjemdahl et al. 1979). Vasoconstriction keeps warm blood buried deep within the blood vessels 
and prevents it from heating the periphery – effectively acting as an indirect method of 
decreasing body temperature. Thus, it is possible that the hypothermia present in UCP1/UCP3 
double-null mice has at least two causes: a global lack of UCPs, and peripheral vasoconstriction 
due to the administration of NE which manifests in the continuous drop in body temperature seen 
in the UCP1/UCP3 double-null animals. A whole-body lack of UCPs could also help explain the 
inability of double-null animals to regain their body temperature – as global thermoregulation is 
compromised by the absence of one or more UCPs.  
Our results contrast with the observations made by Gong et al. When they challenged 
UCP3-null mice with β3-adrenoreceptor specific agonist CL316243 they found no change in 
resting oxygen consumption from WT littermates (Gong et al. 2000). Whereas this agonist is 
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only specific to the β3 group of adrenergic receptors within the murine body, METH and NE 
both act on all three types of β-adrenergic receptors. Thus, one hypothesis to explain the 
difference between these results is that murine UCP3 mediated thermogenesis may occur 
primarily through the β1 and β2 adrenergic receptors in mice. This differs from humans where 
MDMA-mediated thermogenesis occurs through agonism of the α1 and the β3 adrenoreceptors 
suggesting that these mechanisms vary from one species to the other (Sprague et al 2004, 2005). 
However, this theory was disproved by Sprague et al. By pretreating rats with α1-adrenergic 
receptor antagonist, prazosin, and a peripherally selective β3-adrenergic receptor antagonist, 
SR59230A, Sprague and his team abolished the MDMA induced hyperthermia and resulting 
rhabdomyolysis, demonstrating the important, cross-species role mediated by these receptors. 
(Sprague et al. 2004). 
 We have previously shown that WT mice that have had about 70% of their BAT ablated 
still present with a hyperthermic phenotype, suggesting the involvement of SKM UCP3 in 
thermogenesis (Kenaston 2010). Further experiments should be conducted using UCP1/UCP3 
double–null mice crossed to UCP3 SKM overexpressing mice, which overexpress human UCP3 
in SKM only at levels slightly above the physiological norms. This would shed insight onto 
whether adding UCP3 back to SKM would be enough to mediate NE-induced thermogenesis, or 
if this is a phenomenon specifically mediated by the proteins and processes intrinsic to BAT. 
Lastly, these studies are unfinished, and must be replicated using UCP1-/- mice. Despite trying 
to breed animals in a variety of temperatures and conditions, UCP1-/- mice failed to produce 
pups for this study, creating issues in testing a full hypothesis and the interpretation of 
subsequent results.  
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Other studies conducted into the function of UCP3 report incongruent results. For 
example, groups still measure the generation of UCP mRNA following pharmacologic 
intervention rather than assessing increases in protein levels directly (Margareto et al 2001, Mori 
et al. 2004). Messenger RNA in the cytoplasm is incredibly sensitive to degradation by 
microRNA, short interfering RNA, and endonuclease activity among others. While quantifying 
mRNA is an easier technique than assessing UCP3 protein content, quantitative PCR only 
reveals a partial, correlative view of the events occurring in the cell, and must be complimented 
with a quantitative assessment of UCP proteins, as proteins are the key components within cells 
which carry out specialized functions. This is made difficult, however, by the dearth of UCP3 in 
both primary isolated murine BAT cells as well as immortalized BAT cell lines.  In addition, 
following every passage, immortalized adipocytes expressed less and less of UCP1, suggesting 
that the 3D tissue environment is intrinsic in the maintenance and proper function of UCP1 
(unpublished observation). 
Classically, many studies assess the function of UCP3 in both BAT and SKM by 
measuring respiration in isolated mitochondria (Matthias et al. 2000, Nabben et al. 2011). This 
often presents confounding results as the removal of an organelle from its natural environment 
results in the gross perturbation of normal function. These studies also utilize a variety of 
differing buffers, osmotic media, initial TCA substrates as well as varying levels of important 
metal cofactors, ADP, and ATP (Ikuma 1970). As a result, the variation in respiration protocols 
makes it difficult to extrapolate results about UCP3 function in mitochondria. Furthermore, much 
of what is known about UCP3 has been generated by studying this protein within the context of 
SKM, where UCP3 is the only UCP present. Groups have published that the redox environment 
of SKM and BAT varies greatly and could have independent effects on the functions of these 
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proteins depending on the tissue environment (Mailloux et al. 2011, 2012).  This makes the study 
of UCP3 in BAT even more difficult because BAT: a) contains more than one UCP, and b) 
expresses UCP1 at more than 500 levels greater than UCP3 (Harper et al. 2001, 2002). With 
over 50% amino acid homology, separating the effects of one UCP from another is very difficult. 
Alternatively, whole-body approaches to assess UCP3 function have presented their own 
challenges as well. Thermogenic methodologies vary wildly across studies with some groups 
choosing to acclimate their animals from 4 to 30°C from 1 to 24 hours before challenging them 
with thermogenic agonists while others do not pre-acclimate. (Feil et al. 1994, Cunningham et al 
2003, Mills et al 2003, 2004, Sprague et al. 2007).  
Previous experiments have assessed UCP3-null FFA oxidation and found no difference 
between genotypes (Gong et al. 2000, Vidal-puig et al. 2000). Yet, the majority of theses studies 
were conducted in SKM and need to be repeated in BAT. Additionally, because our experiments 
demonstrated UCP3-specific effects following NE administration, future experiments should 
assess whether NE-stimulated lipolysis is affected by removal of UCP3 in BAT as well as SKM. 
Furthermore, no studies have assessed whole body plasma FFA and TG levels following NE 
stimulation in UCP3-null mice. Whole-body ablation of UCP3 could lead to altered lipolytic 
responses and decreases in circulating FFA. This can be recapitulated in vitro by treating 
differentiated BAT and SKM cells with a variety of thermogenic agonists and then measuring 
FFA release into the media.  
Studies have shown that UCP3-null mice have increased levels of superoxide production 
in SKM mitochondria (Vidal-puig et al. 2000). Furthermore, some groups have discovered that 
UCP3 has reactive cysteine residues, which have the capacity to modulate ROS generation by 
the redox cycling of GSH to GSSG (Mailloux RJ, et al. 2011, 2012). Thus, future experiments 
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should assay how UCP3 functions in ROS generation prophylaxis by measuring superoxide 
production, levels of GSH:GSSG, thioredoxin and aconitase levels in  BAT mitochondria of 
varying genotypes. In addition, elevated ROS has the capacity to damage proteins via 
carbonylation, and lipid peroxidation. Studies should assess the extent to which UCP3 ablation 
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